CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today – Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners

Summary

Wells Fargo highlights depression drug companies including Compass Pathways (CMPS) as potential beneficiaries of the next wave of treatments. The analyst note identifies multiple stocks in the psychiatric therapeutics space as worthy of investor attention.